Genomic Differences in Thyroid Cancers From Primary Sites Versus Distant Metastases in Individual Patients: A Clinical Perspective and Preliminary Report
ABSTRACT Background Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling‐risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unc...
Saved in:
Published in | Head & neck Vol. 47; no. 7; pp. 1907 - 1927 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.07.2025
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ABSTRACT
Background
Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling‐risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear.
Methods
Patients with TC and distant metastasis were recruited for genetic analysis.
Results
Using a TC‐specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2–SHTN1 and RFTN1–BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032).
Conclusion
Patterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice. |
---|---|
AbstractList | ABSTRACT
Background
Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling‐risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear.
Methods
Patients with TC and distant metastasis were recruited for genetic analysis.
Results
Using a TC‐specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2–SHTN1 and RFTN1–BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032).
Conclusion
Patterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice. Background Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling‐risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear. Methods Patients with TC and distant metastasis were recruited for genetic analysis. Results Using a TC‐specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2–SHTN1 and RFTN1–BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032). Conclusion Patterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice. Distant metastasis is a leading cause of thyroid cancer (TC)-related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling-risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear. Patients with TC and distant metastasis were recruited for genetic analysis. Using a TC-specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2-SHTN1 and RFTN1-BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032). Patterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice. Distant metastasis is a leading cause of thyroid cancer (TC)-related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling-risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear.BACKGROUNDDistant metastasis is a leading cause of thyroid cancer (TC)-related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling-risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear.Patients with TC and distant metastasis were recruited for genetic analysis.METHODSPatients with TC and distant metastasis were recruited for genetic analysis.Using a TC-specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2-SHTN1 and RFTN1-BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032).RESULTSUsing a TC-specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2-SHTN1 and RFTN1-BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032).Patterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice.CONCLUSIONPatterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice. |
Author | Lin, Yen‐Bo Lu, Jin‐Ying Chu, I Chen, Kuen‐Yuan Yang, Wei‐Shiung Hsih, Wen‐Hui Chen, Chun‐Nan Chen, Pei‐Lung Wu, Ming‐Hsun Lin, Chia‐Hung Chung, An‐Ko Kuo, Shuenn‐Wen Lee, Jih‐Hsiang Wang, Chun‐Wei Nien, Feng‐Jung Cheng, Mei‐Fang Chiu, Wei‐Yih Lin, Chia‐Chi Kuo, Ting‐Chun Wu, Wan‐Chen Chiu, I‐Hsuan Hu, Hsiang‐Wei Wang, Chih‐Yuan Shih, Shyang‐Rong |
Author_xml | – sequence: 1 givenname: Yen‐Bo surname: Lin fullname: Lin, Yen‐Bo organization: National Taiwan University Hospital, Bei‐Hu Branch – sequence: 2 givenname: Hsiang‐Wei surname: Hu fullname: Hu, Hsiang‐Wei organization: National Taiwan University Hospital – sequence: 3 givenname: An‐Ko surname: Chung fullname: Chung, An‐Ko organization: Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine – sequence: 4 givenname: Jin‐Ying surname: Lu fullname: Lu, Jin‐Ying organization: National Taiwan University Hospital – sequence: 5 givenname: Wan‐Chen surname: Wu fullname: Wu, Wan‐Chen organization: National Taiwan University Hospital – sequence: 6 givenname: I‐Hsuan surname: Chiu fullname: Chiu, I‐Hsuan organization: National Taiwan University Hospital – sequence: 7 givenname: I surname: Chu fullname: Chu, I organization: National Taiwan University College of Medicine – sequence: 8 givenname: Chia‐Chi surname: Lin fullname: Lin, Chia‐Chi organization: National Taiwan University Hospital – sequence: 9 givenname: Jih‐Hsiang surname: Lee fullname: Lee, Jih‐Hsiang organization: National Taiwan University Hospital, Hsin‐Chu Branch – sequence: 10 givenname: Feng‐Jung surname: Nien fullname: Nien, Feng‐Jung organization: National Taiwan University Cancer Center – sequence: 11 givenname: Kuen‐Yuan surname: Chen fullname: Chen, Kuen‐Yuan organization: National Taiwan University Hospital – sequence: 12 givenname: Ming‐Hsun surname: Wu fullname: Wu, Ming‐Hsun organization: National Taiwan University Hospital – sequence: 13 givenname: Chun‐Nan surname: Chen fullname: Chen, Chun‐Nan organization: National Taiwan University Hospital – sequence: 14 givenname: Chun‐Wei surname: Wang fullname: Wang, Chun‐Wei organization: National Taiwan University Hospital – sequence: 15 givenname: Ting‐Chun surname: Kuo fullname: Kuo, Ting‐Chun organization: National Taiwan University Hospital – sequence: 16 givenname: Chia‐Hung surname: Lin fullname: Lin, Chia‐Hung organization: National Taiwan University Hospital – sequence: 17 givenname: Mei‐Fang surname: Cheng fullname: Cheng, Mei‐Fang organization: National Taiwan University Hospital – sequence: 18 givenname: Wei‐Yih orcidid: 0000-0003-3124-7121 surname: Chiu fullname: Chiu, Wei‐Yih organization: National Taiwan University Hospital – sequence: 19 givenname: Shuenn‐Wen surname: Kuo fullname: Kuo, Shuenn‐Wen organization: National Taiwan University College of Medicine – sequence: 20 givenname: Wen‐Hui surname: Hsih fullname: Hsih, Wen‐Hui organization: National Taiwan University Hospital, Yun‐Lin Branch – sequence: 21 givenname: Chih‐Yuan orcidid: 0000-0002-6742-3935 surname: Wang fullname: Wang, Chih‐Yuan organization: National Taiwan University College of Medicine – sequence: 22 givenname: Wei‐Shiung surname: Yang fullname: Yang, Wei‐Shiung organization: Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine – sequence: 23 givenname: Pei‐Lung surname: Chen fullname: Chen, Pei‐Lung organization: National Taiwan University Hospital – sequence: 24 givenname: Shyang‐Rong orcidid: 0000-0001-7424-1358 surname: Shih fullname: Shih, Shyang‐Rong email: srshih@ntu.edu.tw organization: National Taiwan University College of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39936351$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1rFTEYhYNU7Icu_AMScKOLafM5M3FXbj-hYtHqdshN3tCUmeSaZCr3p_hvzXWqC8FVDofnHMJ7DtFeiAEQek3JMSWEndyDPWZ9lc_QASWqawgX3d5OC95w0ol9dJjzAyGEt4K9QPtcKd5ySQ_Qz0sIcfIGn3nnIEEwkLEP-O5-m6K3eKWrkzK-SHHCt8lPOm3xF18q9a36c67BXHQo-CMUXVVe8tfB-kdvZz3iW108hJI_4FO8Gn3wZmfW8AZM8Y-AdbC1GkY_-bCr_wybmMpL9NzpMcOrp_cIfb04v1tdNTefLq9XpzeN4ZSTRkpHDbUUVEeMYVYwQWwLbaetVtyxXos1s50mayZVa5hTznRCWel64qhr-RF6t_RuUvw-Qy7D5LOBcdQB4pwHTlvZS8lEX9G3_6APcU6h_m7gjClCpVJdpd48UfN6AjtslqsNf45egfcLYFLMOYH7i1Ay7AYd6qDD70Ere7KwP_wI2_-Dw9X52ZL4BbMhoh0 |
Cites_doi | 10.1186/s12943-018-0786-0 10.1002/lary.28722 10.1089/thy.2015.0020 10.1530/ERC-19-0452 10.1016/j.jtho.2018.09.014 10.1186/s13059-019-1842-9 10.1016/j.bbcan.2017.01.003 10.1158/0008-5472.CAN-09-0727 10.1093/nar/gkq603 10.1186/s12885-021-07888-4 10.1093/bioinformatics/btp324 10.1371/journal.pone.0115383 10.1210/jc.2016-2785 10.3389/fendo.2021.623182 10.1038/s41574-023-00920-6 10.1038/s41588-020-0633-2 10.1089/thy.2019.0052 10.1089/thy.2015.0527 10.1016/j.ygeno.2020.06.020 |
ContentType | Journal Article |
Copyright | 2025 Wiley Periodicals LLC. |
Copyright_xml | – notice: 2025 Wiley Periodicals LLC. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7TK K9. 7X8 |
DOI | 10.1002/hed.28100 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1097-0347 |
EndPage | 1927 |
ExternalDocumentID | 39936351 10_1002_hed_28100 HED28100 |
Genre | researchArticle Journal Article |
GrantInformation_xml | – fundername: Wong‐Yuan Endocrine Fund, Taiwan – fundername: National Taiwan University Hospital – fundername: the Liver Disease Prevention and Treatment Research Foundation, Taiwan – fundername: National Science and Technology Council (Taiwan) funderid: 111‐2314‐B‐002‐194‐MY3 – fundername: National Taiwan University – fundername: Wong-Yuan Endocrine Fund, Taiwan – fundername: National Science and Technology Council (Taiwan) grantid: 111-2314-B-002-194-MY3 |
GroupedDBID | --- .3N .55 .GA .Y3 05W 10A 1L6 1OB 1OC 1ZS 31~ 33P 36B 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADZMN ADZOD AEEZP AEIGN AEIMD AEQDE AEUYR AEYWJ AFBPY AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGYGG AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO EBD EBS EJD EMB EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6P MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V2E W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR X7M XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7TK K9. 7X8 |
ID | FETCH-LOGICAL-c3130-55f1c1d1e970cc2d4240d6e67ada93f28a4b2d7a0b2596c2f9fc749d5f80f1f63 |
IEDL.DBID | DR2 |
ISSN | 1043-3074 1097-0347 |
IngestDate | Fri Jul 11 01:43:35 EDT 2025 Wed Jul 23 07:40:39 EDT 2025 Tue Jun 10 01:31:05 EDT 2025 Thu Jul 31 00:23:31 EDT 2025 Mon Jun 09 09:20:18 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | fusion genes thyroid cancer mutations oncogene metastasis |
Language | English |
License | 2025 Wiley Periodicals LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3130-55f1c1d1e970cc2d4240d6e67ada93f28a4b2d7a0b2596c2f9fc749d5f80f1f63 |
Notes | The first three authors are co‐first authors. Funding This work was supported by Wong‐Yuan Endocrine Fund, Taiwan; the Liver Disease Prevention and Treatment Research Foundation, Taiwan; National Taiwan University; National Taiwan University Hospital; National Science and Technology Council (Taiwan). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-3124-7121 0000-0002-6742-3935 0000-0001-7424-1358 |
PMID | 39936351 |
PQID | 3229015997 |
PQPubID | 996355 |
PageCount | 21 |
ParticipantIDs | proquest_miscellaneous_3165855248 proquest_journals_3229015997 pubmed_primary_39936351 crossref_primary_10_1002_hed_28100 wiley_primary_10_1002_hed_28100_HED28100 |
PublicationCentury | 2000 |
PublicationDate | July 2025 |
PublicationDateYYYYMMDD | 2025-07-01 |
PublicationDate_xml | – month: 07 year: 2025 text: July 2025 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Houston |
PublicationTitle | Head & neck |
PublicationTitleAlternate | Head Neck |
PublicationYear | 2025 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
References | 2009; 69 2009; 25 2018; 17 2010; 38 2021; 21 2021; 12 2017; 2017 2019; 20 2020; 52 2020; 30 2019; 14 2020; 27 2024; 20 2021; 131 2017; 1867 2020; 112 2014; 9 2017; 102 2016; 26 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 Chakravarty D. (e_1_2_8_14_1) 2017; 2017 e_1_2_8_20_1 e_1_2_8_10_1 e_1_2_8_21_1 e_1_2_8_11_1 e_1_2_8_12_1 |
References_xml | – volume: 20 start-page: 93 issue: 2 year: 2024 end-page: 110 article-title: Genomic Alterations in Thyroid Cancer: Biological and Clinical Insights publication-title: Nature Reviews Endocrinology – volume: 52 start-page: 692 issue: 7 year: 2020 end-page: 700 article-title: Lymph Node Metastases Develop Through a Wider Evolutionary Bottleneck Than Distant Metastases publication-title: Nature Genetics – volume: 69 start-page: 4885 issue: 11 year: 2009 end-page: 4893 article-title: Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine‐Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for , , and publication-title: Cancer Research – volume: 26 start-page: 1 issue: 1 year: 2016 end-page: 133 article-title: 2015 American Thyroid Association Management Guidelines for Adult Patients With Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer publication-title: Thyroid – volume: 102 start-page: 1898 issue: 6 year: 2017 end-page: 1907 article-title: TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 21 issue: 1 year: 2021 article-title: Multi‐Omics Analysis of Genomics, Epigenomics and Transcriptomics for Molecular Subtypes and Core Genes for Lung Adenocarcinoma publication-title: BMC Cancer – volume: 25 start-page: 1754 issue: 14 year: 2009 end-page: 1760 article-title: Fast and Accurate Short Read Alignment With Burrows–Wheeler Transform publication-title: Bioinformatics – volume: 20 issue: 1 year: 2019 article-title: Accuracy Assessment of Fusion Transcript Detection via Read‐Mapping and De Novo Fusion Transcript Assembly‐Based Methods publication-title: Genome Biology – volume: 1867 start-page: 151 issue: 2 year: 2017 end-page: 161 article-title: Tumor Evolution: Linear, Branching, Neutral or Punctuated? publication-title: Biochimica et Biophysica Acta, Reviews on Cancer – volume: 26 start-page: 672 issue: 5 year: 2016 end-page: 682 article-title: Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer publication-title: Thyroid – volume: 30 start-page: 42 issue: 1 year: 2020 end-page: 56 article-title: Whole‐Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer publication-title: Thyroid – volume: 27 start-page: 285 issue: 5 year: 2020 end-page: 293 article-title: Genetic Profile of Advanced Thyroid Cancers in Relation to Distant Metastasis publication-title: Endocrine‐Related Cancer – volume: 2017 year: 2017 article-title: OncoKB: A Precision Oncology Knowledge Base publication-title: Journal of Clinical Oncology: Precision Oncology – volume: 112 start-page: 3306 issue: 5 year: 2020 end-page: 3314 article-title: lncRNA‐RP11‐156p1.3, Novel Diagnostic and Therapeutic Targeting via CRISPR/Cas9 Editing in Hepatocellular Carcinoma publication-title: Genomics – volume: 17 issue: 1 year: 2018 article-title: Novel Targeted Therapies and Immunotherapy for Advanced Thyroid Cancers publication-title: Molecular Cancer – volume: 12 year: 2021 article-title: Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ? publication-title: Frontiers in Endocrinology – volume: 131 start-page: 237 issue: 1 year: 2021 end-page: 244 article-title: Prevalence and Risk of Metastatic Thyroid Cancers and Management Outcomes: A National Perspective publication-title: Laryngoscope – volume: 38 issue: 16 year: 2010 article-title: ANNOVAR: Functional Annotation of Genetic Variants From High‐Throughput Sequencing Data publication-title: Nucleic Acids Research – volume: 9 issue: 12 year: 2014 article-title: Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications publication-title: PLoS One – volume: 14 start-page: 54 issue: 1 year: 2019 end-page: 62 article-title: Detection of Known and Novel FGFR Fusions in Non‐Small Cell Lung Cancer by Comprehensive Genomic Profiling publication-title: Journal of Thoracic Oncology – ident: e_1_2_8_4_1 doi: 10.1186/s12943-018-0786-0 – ident: e_1_2_8_2_1 doi: 10.1002/lary.28722 – ident: e_1_2_8_3_1 doi: 10.1089/thy.2015.0020 – ident: e_1_2_8_11_1 doi: 10.1530/ERC-19-0452 – ident: e_1_2_8_19_1 doi: 10.1016/j.jtho.2018.09.014 – ident: e_1_2_8_15_1 doi: 10.1186/s13059-019-1842-9 – volume: 2017 year: 2017 ident: e_1_2_8_14_1 article-title: OncoKB: A Precision Oncology Knowledge Base publication-title: Journal of Clinical Oncology: Precision Oncology – ident: e_1_2_8_17_1 doi: 10.1016/j.bbcan.2017.01.003 – ident: e_1_2_8_10_1 doi: 10.1158/0008-5472.CAN-09-0727 – ident: e_1_2_8_13_1 doi: 10.1093/nar/gkq603 – ident: e_1_2_8_21_1 doi: 10.1186/s12885-021-07888-4 – ident: e_1_2_8_12_1 doi: 10.1093/bioinformatics/btp324 – ident: e_1_2_8_18_1 doi: 10.1371/journal.pone.0115383 – ident: e_1_2_8_9_1 doi: 10.1210/jc.2016-2785 – ident: e_1_2_8_7_1 doi: 10.3389/fendo.2021.623182 – ident: e_1_2_8_16_1 doi: 10.1038/s41574-023-00920-6 – ident: e_1_2_8_6_1 doi: 10.1038/s41588-020-0633-2 – ident: e_1_2_8_8_1 doi: 10.1089/thy.2019.0052 – ident: e_1_2_8_5_1 doi: 10.1089/thy.2015.0527 – ident: e_1_2_8_20_1 doi: 10.1016/j.ygeno.2020.06.020 |
SSID | ssj0003642 |
Score | 2.4515634 |
Snippet | ABSTRACT
Background
Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per... Distant metastasis is a leading cause of thyroid cancer (TC)-related deaths. Genetic profiling is typically limited to one sample per patient due to cost and... Background Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per patient due to... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1907 |
SubjectTerms | Adult Aged Female Fibroblast growth factor receptor 2 fusion genes Genetic analysis High-Throughput Nucleotide Sequencing Humans Male Metastases Metastasis Middle Aged Mutation mutations Neoplasm Metastasis - genetics oncogene Thyroid cancer Thyroid gland Thyroid Neoplasms - genetics Thyroid Neoplasms - pathology |
Title | Genomic Differences in Thyroid Cancers From Primary Sites Versus Distant Metastases in Individual Patients: A Clinical Perspective and Preliminary Report |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhed.28100 https://www.ncbi.nlm.nih.gov/pubmed/39936351 https://www.proquest.com/docview/3229015997 https://www.proquest.com/docview/3165855248 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VPfXCQ-URKJVBHLhkGzuOk9BT1XZZkIoqaKUekCI_1Qo1izbZA_wT_i1jO8mqICTEzUns-DUz_vyYzwCvK5XRShdVyi3PUy60SbGbZUqFRJOZCyWCh9zZR7G45B-uiqstOBx9YSI_xLTg5jUj2Guv4FJ1BxvS0GtrZqzCB7S__qyWB0SfNtRRueBxpxOLgHLMR1ahjB1MKe-ORX8AzLt4NQw48_vwZSxqPGfydbbu1Uz_-I3F8T_r8gDuDUCUHEXJeQhbtt2Fn-9scFMmJ8O9KWhFyE1LLq6_r5Y3hhx7GVl1ZL5a3pLzSFRBPiNq7YhfeFt3mNDDzZ6c2V5iqIvp309uX-Q8Erl2b8kRGUhJ8eXG5ZPI1uCvsUK3wVWYxCnCI7icn14cL9Lh8oZU5zgupkXhqKaG2rrMtGaGI3QwwopSGlnnjlWSK2ZKmSmcgAnNXO10yWtTuCpz1In8MWy3y9Y-BWKsUZLrslaejJAaaV1ZIpBVtHCefzCBV2M3Nt9i1ZvIxswabNkmtGwCe2MHN4Oadk3u2e4R0NVlAi-nz6hgftdEtna5xjgUQVpRMF4l8CQKxpSLR3eI2GgCb0L3_j37ZnF6EgLP_j3qc9hh_rbhcDh4D7b71dq-QAjUq_0g678A4JsCTw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcoALD_FoSikGceCSbZw4TlL1UrVdttCtKthKvaDIr6gVarbaZA_wT_i3jO0kqxYhIW5OYsePmbE_P-YzwPtcRjRXaR4yw5KQcaVDFLMIKRfYZSZccuchNz3lk3P26SK9WIO93hfG80MMC27WMlx_bQ3cLkjvrFhDL40exTk-3IP79kZvN6H6siKPSjjze51YCNRk1vMKRfHOkPT2aPQHxLyNWN2QM34M3_rC-pMm30fLVo7Uzzs8jv9bmyfwqMOiZN8rz1NYM_Uz-PXROE9lcthdnYIdCbmqyezyx2J-pcmBVZNFQ8aL-TU581wV5CsC14bYtbdlgwkt4mzJ1LQCQ41Pfzx4fpEzz-Xa7JJ90vGS4suV1ycRtcZfY42unbcw8bOE53A-PpodTMLu_oZQJTg0hmlaUUU1NUUWKRVrhuhBc8MzoUWRVHEumIx1JiKJczCu4qqoVMYKnVZ5VNGKJy9gvZ7XZgOINloKprJCWj5CqoWpsgyxrKRpZSkIA3jXy7G88VUvPSFzXGLLlq5lA9jqJVx2ltqUiSW8R0xXZAG8HT6jjdmNE1Gb-RLjUMRpaRqzPICXXjOGXCzAQ9BGA_jg5Pv37MvJ0aELbP571DfwYDKbnpQnx6efX8HD2F4-7M4Kb8F6u1ia14iIWrntFP839PEGag |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFH4qRUJcWMTSdAGDOHDJNE4cJ2lPVafDFGg1glbqASlyvKgVaqaaZA7wT_i3fbaTjApCQtycxI6X9579eXmfAd7lVURzmeYh0ywJGZcqRDGLkHKBXWbCK-485E5O-fScfbxIL9Zgv_eF8fwQw4KbtQzXX1sDv1Fmd0UaeqnVKM7x4R7cZzzKrUqPv6y4oxLO_FYnlgEVmfW0QlG8OyS9Oxj9gTDvAlY34kwew7e-rP6gyffRsq1G8udvNI7_WZkn8KhDouTAq85TWNP1M_j1QTs_ZTLuLk7BboRc1eTs8sdifqXIoVWSRUMmi_k1mXmmCvIVYWtD7MrbssGEFm-25ES3AkONT388-H2RmWdybfbIAelYSfHlyueTiFrhr7FC185XmPg5wnM4nxydHU7D7vaGUCY4MIZpaqikiuoii6SMFUPsoLjmmVCiSEycC1bFKhNRhTMwLmNTGJmxQqUmjww1PHkB6_W81htAlFaVYDIrKstGSJXQJssQyVY0NZaAMIC3vRjLG1_10tMxxyW2bOlaNoDtXsBlZ6dNmVi6e0R0RRbAm-EzWpjdNhG1ni8xDkWUlqYxywN46RVjyMXCO4RsNID3Trx_z76cHo1dYPPfo76GB7PxpPx8fPppCx7G9uZhd1B4G9bbxVLvIBxqq1dO7W8B_-QFIg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genomic+Differences+in+Thyroid+Cancers+From+Primary+Sites+Versus+Distant+Metastases+in+Individual+Patients%3A+A+Clinical+Perspective+and+Preliminary+Report&rft.jtitle=Head+%26+neck&rft.au=Lin%2C+Yen%E2%80%90Bo&rft.au=Hu%2C+Hsiang%E2%80%90Wei&rft.au=Chung%2C+An%E2%80%90Ko&rft.au=Lu%2C+Jin%E2%80%90Ying&rft.date=2025-07-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1043-3074&rft.eissn=1097-0347&rft.volume=47&rft.issue=7&rft.spage=1907&rft.epage=1927&rft_id=info:doi/10.1002%2Fhed.28100&rft.externalDBID=10.1002%252Fhed.28100&rft.externalDocID=HED28100 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-3074&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-3074&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-3074&client=summon |